---
title: "ALDX.US (ALDX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ALDX.US/news.md"
symbol: "ALDX.US"
name: "ALDX.US"
parent: "https://longbridge.com/en/quote/ALDX.US.md"
datetime: "2026-05-22T01:13:14.065Z"
locales:
  - [en](https://longbridge.com/en/quote/ALDX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ALDX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ALDX.US/news.md)
---

# ALDX.US (ALDX.US) — Related News

### [15:10 ETINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aldeyra Therapeutics, Inc. Of Class Action Lawsuit and Upcoming Deadlines - ALDX](https://longbridge.com/en/news/287263227.md)
*2026-05-21T19:12:19.000Z*
> Pomerantz Law Firm has filed a class action lawsuit against Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) for alleged securi

### [09:13 ETALDX EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026](https://longbridge.com/en/news/287227597.md)
*2026-05-21T13:14:05.000Z*
> Faruqi & Faruqi, LLP is investigating claims against Aldeyra Therapeutics (ALDX) and reminds investors of the May 29, 20

### [ROSEN, A LEADING LAW FIRM, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX](https://longbridge.com/en/news/286835278.md)
*2026-05-19T01:08:00.000Z*
> Rosen Law Firm urges investors of Aldeyra Therapeutics, Inc. who purchased securities between November 3, 2023, and Marc

### [11:35 ETALDX INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Aldeyra Therapeutics (ALDX) Investors of Securities Class Action Deadline on May 29, 2026](https://longbridge.com/en/news/286440517.md)
*2026-05-14T15:37:18.000Z*
> Faruqi & Faruqi, LLP is investigating potential claims against Aldeyra Therapeutics (NASDAQ: ALDX) and reminds investors

### [19:01 ETALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm](https://longbridge.com/en/news/285854271.md)
*2026-05-10T23:02:21.000Z*
> Rosen Law Firm has filed a securities fraud class action lawsuit against Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) for i

### [14:43 ETALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm](https://longbridge.com/en/news/285250148.md)
*2026-05-05T18:44:00.000Z*
> Rosen Law Firm has filed a securities fraud class action lawsuit against Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) for i

### [Aldeyra Therapeutics updates reproxalap NDA data, outlines FDA meeting and AbbVie option](https://longbridge.com/en/news/284917782.md)
*2026-05-01T15:53:01.000Z*
> Aldeyra Therapeutics has updated its corporate overview regarding reproxalap, revealing standardized efficacy estimates 

### [19:42 ETINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aldeyra Therapeutics, Inc. Of Class Action Lawsuit and Upcoming Deadlines - ALDX](https://longbridge.com/en/news/284851247.md)
*2026-04-30T23:52:21.000Z*
> Pomerantz LLP has filed a class action lawsuit against Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) for alleged securities